Related Experiment Videos
Alterations of the p53, Rb and MDM2 genes in osteosarcoma
1Hematology and Oncology, Children's Hospital, Cincinnati, Ohio 45229, USA.
Abstract:
Molecular defects affecting tumor-suppressor genes are an important step in the genesis of sarcomas. For example, inheritance of a defective Rb or p53 gene predisposes the carrier to develop osteosarcoma, among other malignancies. In this study, we have assessed the occurrence of p53, Rb and MDM2 alterations in the same samples of osteosarcomas, along with representative samples of various other sarcomas. Point mutations of the p53 gene were found in 13 of 42 osteosarcomas and 1 of 8 leiomyosarcomas, and gross rearrangement of the p53 gene was demonstrated in 5 of 37 osteosarcomas. The retinoblastoma susceptibility gene (Rb) was either rearranged or deleted in 7 of 37 osteosarcomas, 1 of 7 soft-tissue sarcomas and 1 of 4 Ewing sarcomas. Remarkably, 5 of the osteosarcomas having Rb alterations also had p53 mutations. Amplification and overexpression of the MDM2 oncogene may lead to increased MDM2-p53 binding resulting in inactivation of p53 function. A two- to threefold increase in the copy number of MDM2 was detected in 7 of 37 samples, 5 of which were osteosarcomas. Amplification of the MDM2 gene occurred independently of p53 mutation; one sample having threefold amplification of MDM2 also had a p53 mutation. In summary, 34 alterations of the p53, Rb and MDM2 genes were found in 26 of 42 (62%) osteosarcomas.
Insights
Genetic alterations in tumor suppressor genes like p53 and Rb, and the MDM2 oncogene, are common in sarcomas, particularly osteosarcoma. These molecular defects are crucial in sarcoma development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Molecular defects in tumor-suppressor genes are key in sarcoma development.
- Inherited mutations in Rb or p53 genes increase susceptibility to osteosarcoma and other cancers.
- The MDM2 oncogene can inactivate p53 function through amplification and overexpression.
Purpose of the Study:
- To investigate the co-occurrence of alterations in p53, Rb, and MDM2 genes in osteosarcomas and other sarcomas.
- To determine the frequency and interplay of these genetic alterations in sarcoma pathogenesis.
Main Methods:
- Analysis of p53 gene mutations and rearrangements.
- Assessment of retinoblastoma susceptibility gene (Rb) rearrangements and deletions.
- Detection of MDM2 gene amplification and copy number variations.
Main Results:
- p53 mutations were found in 13/42 osteosarcomas and 1/8 leiomyosarcomas; gross rearrangements in 5/37 osteosarcomas.
- Rb alterations (rearrangement or deletion) occurred in 7/37 osteosarcomas, 1/7 soft-tissue sarcomas, and 1/4 Ewing sarcomas.
- MDM2 gene amplification (2- to 3-fold) was detected in 7/37 samples, primarily osteosarcomas (5/7).
Conclusions:
- A significant proportion of osteosarcomas (62%) exhibit alterations in p53, Rb, or MDM2.
- Co-occurring alterations in Rb and p53 were observed in 5 osteosarcomas.
- MDM2 amplification can occur independently of p53 mutations, suggesting complex regulatory mechanisms in sarcoma.